Evaluation of a Validated Biomarker Test in Combination With a Symptom Index to Predict Ovarian Malignancy.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27870706)

Published in Int J Gynecol Cancer on November 17, 2016

Authors

Renata R Urban1, Alan Smith, Kathy Agnew, Vinicius Bonato, Barbara A Goff

Author Affiliations

1: *Division of Gynecologic Oncology, University of Washington Medical Center, Seattle, WA; †Applied Clinical Intelligence, Bala Cynwyd, PA; and ‡Vermillion, Inc, Austin, TX.

Articles by these authors

(truncated to the top 100)

OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol (2012) 6.08

Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J (2004) 2.39

Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay. Obstet Gynecol (2011) 2.38

The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations. Cancer (2010) 2.13

Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab (2006) 2.10

Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis (2002) 2.09

Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am (2003) 1.97

Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood (2003) 1.92

Honey bees navigate according to a map-like spatial memory. Proc Natl Acad Sci U S A (2005) 1.91

Trends in treatment of advanced epithelial ovarian cancer in the Medicare population. Gynecol Oncol (2011) 1.77

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer. Gynecol Oncol (2009) 1.77

Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol (2011) 1.74

Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer. Am J Obstet Gynecol (2005) 1.72

Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol (2002) 1.72

Combining a symptoms index with CA 125 to improve detection of ovarian cancer. Cancer (2008) 1.53

Flavonoid effects on normal and leukemic cells. Leuk Res (2003) 1.52

Alternate molecular genetic pathways in ovarian carcinomas of common histological types. Hum Pathol (2007) 1.49

Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study. Cancer (2011) 1.47

Complete ultrasonography of trauma in screening blunt abdominal trauma patients is equivalent to computed tomographic scanning while reducing radiation exposure and cost. J Trauma Acute Care Surg (2015) 1.44

An evaluation of cervical cancer in women age sixty and over. Gynecol Oncol (2008) 1.43

Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors. Obstet Gynecol (2011) 1.30

An experiential interdisciplinary quality improvement education initiative. Am J Med Qual (2006) 1.27

Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota. AIDS Res Hum Retroviruses (2010) 1.26

Identification and sequencing of bacterial rDNAs in culture-negative amniotic fluid from women in premature labor. Am J Perinatol (2004) 1.23

Intracellular accumulation of human immunodeficiency virus protease inhibitors. Antimicrob Agents Chemother (2002) 1.21

Estimating volume of cervicovaginal secretions in cervicovaginal lavage fluid collected for measurement of genital HIV-1 RNA levels in women. J Clin Microbiol (2010) 1.17

Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. Gynecol Oncol (2008) 1.15

The relationship between racial identity, income, stress and C-reactive protein among parous women: implications for preterm birth disparity research. J Natl Med Assoc (2008) 1.14

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas. Mol Cancer (2009) 1.12

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy. Am J Obstet Gynecol (2006) 1.12

Vignette-based study of ovarian cancer screening: do U.S. physicians report adhering to evidence-based recommendations? Ann Intern Med (2012) 1.12

Self-assessment of resident surgical skills: is it feasible? Am J Obstet Gynecol (2005) 1.11

Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study. Cancer (2011) 1.11

Prevalence and risks for bacterial vaginosis in women who have sex with women. Sex Transm Dis (2010) 1.09

The toxicity of textile reactive azo dyes after hydrolysis and decolourisation. J Biotechnol (2003) 1.05

MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival. Genes Chromosomes Cancer (2010) 1.05

Patterns of spread and recurrence of sex cord-stromal tumors of the ovary. Gynecol Oncol (2011) 1.04

Distribution of genital Lactobacillus strains shared by female sex partners. J Infect Dis (2009) 1.03

Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms. Cancer Lett (2010) 1.01

Factors affecting risk of mortality in women with vaginal cancer. Obstet Gynecol (2009) 0.99

The ontogeny of bumblebee flight trajectories: from naïve explorers to experienced foragers. PLoS One (2013) 0.97

Stratigraphy of the Anthropocene. Philos Trans A Math Phys Eng Sci (2011) 0.97

A new curriculum for hysteroscopy training as demonstrated by an objective structured assessment of technical skills (OSATS). Am J Obstet Gynecol (2005) 0.97

A six-year study of surgical teaching and skills evaluation for obstetric/gynecologic residents in porcine and inanimate surgical models. Am J Obstet Gynecol (2005) 0.96

Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer. J Altern Complement Med (2013) 0.96

PecSys: in situ gelling system for optimised nasal drug delivery. Expert Opin Drug Deliv (2009) 0.96

Pelvic exenteration in the age of modern chemoradiation. Gynecol Oncol (2011) 0.95

Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer. Gynecol Oncol (2011) 0.95

Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay. Gynecol Oncol (2012) 0.94

Chitosan-based delivery systems for mucosal vaccines. Expert Opin Drug Deliv (2012) 0.94

Dietary nitrate does not enhance running performance in elite cross-country skiers. Med Sci Sports Exerc (2012) 0.93

Expedient pulmonary embolectomy for acute pulmonary embolism: improved outcomes. Interact Cardiovasc Thorac Surg (2008) 0.92

Common polymorphisms in TP53 and MDM2 and the relationship to TP53 mutations and clinical outcomes in women with ovarian and peritoneal carcinomas. Genes Chromosomes Cancer (2007) 0.92

Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreduction. Gynecol Oncol (2010) 0.92

Identification of ovarian cancer symptoms in health insurance claims data. J Womens Health (Larchmt) (2010) 0.91

Development of in vitro models to demonstrate the ability of PecSys®, an in situ nasal gelling technology, to reduce nasal run-off and drip. Drug Dev Ind Pharm (2012) 0.91

Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinoma. J Immunother (2012) 0.90

Comparative gene expression profiling in human-induced pluripotent stem cell--derived cardiocytes and human and cynomolgus heart tissue. Toxicol Sci (2012) 0.90

Evolution of a cichlid fish in a Lake Malawi satellite lake. Proc Biol Sci (2007) 0.90

Vaginal hydrolytic enzymes, immunoglobulin A against Gardnerella vaginalis toxin, and risk of early preterm birth among women in preterm labor with bacterial vaginosis or intermediate flora. Am J Obstet Gynecol (2002) 0.90

Uterine papillary serous carcinoma: what have we learned over the past quarter century? Gynecol Oncol (2005) 0.89

The three-phase model of cardiac arrest as applied to ventricular fibrillation in a large, urban emergency medical services system. Resuscitation (2005) 0.88

Pharyngeal gonorrhoea - is dual therapy the way forward? Int J STD AIDS (2007) 0.88

Glassy cell carcinoma of the cervix revisited. Gynecol Oncol (2002) 0.88

Clinical evaluation of the Determine HIV-1/2 Ag/Ab Combo test. J Infect Dis (2012) 0.87

Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medications. Cancer Causes Control (2002) 0.86

Common polymorphism in interleukin 6 influences survival of women with ovarian and peritoneal carcinoma. Gynecol Oncol (2006) 0.85

Pneumococcal serotypes from acute otitis media in rural Kentucky. Pediatr Infect Dis J (2002) 0.85

Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly. Obstet Gynecol (2011) 0.85

Impact of allergic rhinitis and its treatment on the pharmacokinetics of nasally administered fentanyl. Int J Clin Pharmacol Ther (2013) 0.84

Nuclear waste transportation: case studies of identifying stakeholder risk information needs. Environ Health Perspect (2003) 0.84

Isolation and characterisation of tilapia beta-actin promoter and comparison of its activity with carp beta-actin promoter. Biochim Biophys Acta (2003) 0.83

Changes in the vaginal microenvironment with metronidazole treatment for bacterial vaginosis in early pregnancy. J Womens Health (Larchmt) (2009) 0.83

Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium. Gynecol Oncol (2005) 0.83

Effect of sexual activity on vaginal colonization with hydrogen peroxide-producing lactobacilli and Gardnerella vaginalis. Sex Transm Dis (2011) 0.82

Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer. Gynecol Oncol (2009) 0.82

FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence. Gynecol Oncol (2011) 0.82

Using multiple sources to improve and measure case ascertainment in surveillance studies: 20 years of the British Paediatric Surveillance Unit. J Public Health (Oxf) (2006) 0.82

Value of symptom-triggered diagnostic evaluation for ovarian cancer. Obstet Gynecol (2014) 0.82

Silver(I) Complexes of the Derivatized Crown Thioether Ligands 3,6,9,12,15,18-Hexathianonadecanol and 3,6,9,13,16,19-Hexathiaicosanol. Determination of Stability Constants and the Crystal Structures of [Ag(19-aneS6-OH)][CF(3)SO(3)] and [Ag(20-aneS6-OH)][BF(4)]. Inorg Chem (1996) 0.81

Novel drugs targeting the androgen receptor pathway in prostate cancer. Cancer Metastasis Rev (2014) 0.81

Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations. Eur J Pharm Sci (2005) 0.81

Involvement in decision-making about treatment and ovarian cancer survivor quality of life. Gynecol Oncol (2011) 0.81

Microparticles from ovarian carcinomas are shed into ascites and promote cell migration. Int J Gynecol Cancer (2012) 0.81

Effects of pregnancy and bacterial vaginosis on proinflammatory cytokine and secretory leukocyte protease inhibitor concentrations in vaginal secretions. J Pregnancy (2010) 0.81

The significance of psammoma bodies in screening cervical cytologic smears. Am J Obstet Gynecol (2003) 0.80

The abandoned radical hysterectomy for cervical cancer: clinical predictors and outcomes. Obstet Gynecol Int (2010) 0.80

Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep. J Pharm Pharmacol (2005) 0.80

Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative. Gynecol Oncol (2013) 0.80

A validated biomarker panel to identify peripheral artery disease. Vasc Med (2012) 0.80

Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers. Neoplasia (2010) 0.79

Surgical education: what role should gynecologic oncologists play? Gynecol Oncol (2008) 0.79

Guideline-inconsistent breast cancer screening for women over 50: a vignette-based survey. J Gen Intern Med (2013) 0.79

The temporal stability of the Symptom Index among women at high-risk for ovarian cancer. Gynecol Oncol (2009) 0.79

Training the next generation of minimally invasive surgeons. J Minim Invasive Gynecol (2009) 0.77

Accuracy of ovarian and colon cancer risk assessments by U.S. physicians. J Gen Intern Med (2014) 0.77

Nonrecommended breast and colorectal cancer screening for young women: a vignette-based survey. Am J Prev Med (2012) 0.77

Variation in microbiologic profiles among pregnant women with bacterial vaginosis. Am J Obstet Gynecol (2005) 0.77

Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass. Am J Obstet Gynecol (2013) 0.77

Detection of hydrogen peroxide-producing Lactobacillus species in the vagina: a comparison of culture and quantitative PCR among HIV-1 seropositive women. BMC Infect Dis (2012) 0.77